Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127590671 | 12759067 | 1 | I | 2014 | 20160908 | 20160919 | 20160919 | EXP | BR-PFIZER INC-2016436007 | PFIZER | 61.00 | YR | F | Y | 0.00000 | 20160919 | CN | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127590671 | 12759067 | 1 | PS | ATENOLOL. | ATENOLOL | 1 | 50 MG | 73676 | 50 | MG | |||||||||
127590671 | 12759067 | 2 | SS | ATACAND HCT | CANDESARTAN CILEXETILHYDROCHLOROTHIAZIDE | 1 | Oral | 16/12.5 MG EVERY DAY | U | 0 | TABLET | ||||||||
127590671 | 12759067 | 3 | SS | CALCIUM | CALCIUM | 1 | UNKNOWN DOSE | 0 | |||||||||||
127590671 | 12759067 | 4 | C | NORVASC | AMLODIPINE BESYLATE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127590671 | 12759067 | 2 | Hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127590671 | 12759067 | OT |
127590671 | 12759067 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127590671 | 12759067 | Blood pressure increased | |
127590671 | 12759067 | Calcium intoxication | |
127590671 | 12759067 | Chest pain | |
127590671 | 12759067 | Fatigue | |
127590671 | 12759067 | Intentional product misuse | |
127590671 | 12759067 | Thyroid cancer |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |